RhoA with Associated TRAb or FT3 in the Diagnosis and Prediction of Graves’ Ophthalmopathy
Table 1
Comparison of FT3\FT4\TSH endpoint values and baseline values between the two groups of patients.
Parameters
GO-free
GO
value
Basal RhoA level
25.09 (14.77, 26.11)
<0.001
Endpoint RhoA level
0.1643
RhoA difference
-18.03 (-20.69, -10.95)
<0.001
Basal FT3 level
13.00 (8.81, 17.17)
21.82 (12.35, 36.38)
0.027
Endpoint of FT3
3.89 (3.36, 4.71)
3.97 (3.60, 4.92)
0.407
FT3 difference
-9.35 (-13.28, -5.17)
-17.45 (-31.18, -8.93)
0.036
Basal FT4 levels
28.08 (23.24, 33.60)
30.72 (25.38, 43.33)
0.215
Endpoint of FT4
10.38 (8.87, 11.24)
10.29 (8.27, 12.91)
0.979
FT4 difference
-17.83 (-24.84, -12.58)
-21.52 (-33.59, -15.25)
0.130
Basal TSH levels
0.004 (0.004, 0.004)
0.004 (0.004, 0.004)
0.960
Endpoint of TSH
0.442 (0.142, 3.889)
2.425 (0.048, 5.209)
0.581
TSH difference
0.440 (0.100, 3.878)
2.425 (0.045, 5.203)
0.546
RhoA difference: difference between the RhoA endpoint value and the basal level. FT3 difference: difference between the FT3 endpoint value and the basal level. FT4 difference: difference between the FT4 endpoint value and basal level. TSH difference: difference between the TSH endpoint value and basal level. Statistically significant results are in bold.
